Hyperfractionated radiotherapy and concurrent low-dose daily carboplatin/paclitaxel in patients with stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II study.

Jeremic, Branislav; Milicic, Biljana R; Acimovic, Ljubisa; Milisavljevic, Slobodan S

Results

eNauka > Results > Hyperfractionated radiotherapy and concurrent low-dose daily carboplatin/paclitaxel in patients with stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II study.

Title:	Hyperfractionated radiotherapy and concurrent low-dose daily carboplatin/paclitaxel in patients with stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II study.
Authors:	Jeremic, Branislav; Milicic, Biljana R; Acimovic, Ljubisa; Milisavljevic, Slobodan S
Issue Date:	2004
Publication:	JOURNAL OF CLINICAL ONCOLOGY
ISSN:	0732-183X Journal of Clinical Oncology Search Idenfier
Type:	Conference Paper
Collation:	vol. 22 br. 14 str. 7164
WoS-ID:	000223512402605
URI:	https://enauka.gov.rs/handle/123456789/803547
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

1
WEB OF SCIENCE^TM

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM